Overview
Corporate Summary
Gain Therapeutics is redefining drug discovery with its See-Tx™ target identification platform. By identifying and optimizing allosteric binding sites that have never before been targeted, Gain is unlocking new treatment options for difficult-to-treat disorders characterized by protein misfolding.
Upcoming Events
|
April 28, 2021 at 4:00 PM EST
B. Riley Securities’ Virtual Neuroscience Conference
|
|
May 1-4, 2021
International Association of Parkinsonism and Related Disorders (IAPRD) 2021 World Congress
|
|
May 21, 2021
Oppenheimer's Rare & Orphan Disease Summit
|
Press Releases
-
May 03 ,2021
Compounds reverse the neurodegenerative process observed in a Parkinson’s disease in vivo model Compounds are novel allosteric regulators that bind, stabilize and restore activity of mutated GCase Compounds decrease both phosphorylated and aggregatedα-synuclein levels in vitro and in vivo BETHESDA, Md., May 03, 2021 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (NASDAQ: GANX) (“Gain”), a biotechnology company focused on redefining drug discovery by using super-computational methods to target...
Apr 27 ,2021BETHESDA, Md., April 27, 2021 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (NASDAQ: GANX) (“Gain”) a biotechnology company focused on redefining drug discovery by identifying and optimizing allosteric binding sites that have never before been targeted, today announced that Eric Richman, Chief Executive Officer of Gain Therapeutics, will present a corporate overview at the B. Riley Securities’ Virtual Neuroscience Conference being held on April 28 - 29. B. Riley Securities’ Virtual Neuroscience...
Apr 22 ,2021Abstract highlighting Gain’s STAR candidate for Parkinson’s disease selected as one of the 10 Best Abstracts at the conference BETHESDA, Md., April 22, 2021 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (NASDAQ: GANX) (“Gain”), a biotechnology company focused on redefining drug discovery by identifying and optimizing allosteric binding sites that have never before been targeted, today announced a poster presentation at the International Association of Parkinsonism and Related Disorders (IAPRD) 2021...
Stock Information
GANXContact IR
Company
GAIN THERAPEUTICS INC.
4800 Hampden Ln, St 200
Bethesda, MD 20814,
United StatePhone: +1 301 500 1556
Investor Relations
LifeSci Advisors, LLC
Dan Ferry
1 International Place
14th Floor
Boston, MA 02110Phone: +1 617-430-7576
This email address is being protected from spambots. You need JavaScript enabled to view it.